Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
1.820
+0.030 (1.68%)
At close: Apr 17, 2024, 4:00 PM
1.790
-0.030 (-1.65%)
After-hours: Apr 17, 2024, 7:33 PM EDT

Aadi Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018201720162015
Market Capitalization
4550313505462569129--
Market Cap Growth
--84.17%-37.97%992.91%82.44%-63.32%-46.34%---
Enterprise Value
-63-5814235652-136108110
PE Ratio
-0.75-0.75-5.17-4.56-10.34-1.09-6.64-5.75--
PS Ratio
1.822.0320.57450.533.17-3.42---
PB Ratio
0.420.471.983.70-3.710.691.187.38--
P/FCF Ratio
-0.78-0.78-6.25-22.46-3.64-1.05-11.80-6.81--
P/OCF Ratio
-0.83-0.83-6.31-22.50-3.64-1.06-11.88-6.81--
EV/Sales Ratio
-2.38-2.389.34318.043.56-0.31---
EV/EBITDA Ratio
0.890.89-2.38-3.26-20.910.56-0.61-5.10-0.65-6.15
EV/EBIT Ratio
0.890.89-2.36-3.26-19.530.56-0.61-5.09-0.65-6.15
EV/FCF Ratio
0.910.91-2.84-15.85-4.090.54-1.09-5.73-0.68-6.51
Debt / Equity Ratio
0.010.010.010.00-0.820.00---0.14-0.86
Debt / EBITDA Ratio
-0.02-0.02-0.03-0.01-4.13-0.01---0.75-6.95
Debt / FCF Ratio
-0.02-0.02-0.03-0.03-0.81-0.01---0.78-7.36
Quick Ratio
4.334.339.269.760.6211.5711.485.650.110.09
Current Ratio
4.724.729.569.900.6211.8711.735.820.150.09
Asset Turnover
0.160.160.090.010.3900.3700-
Interest Coverage
-283.70-283.70-262.10-164.55-3.27---201.31-34.22-2.73
Return on Equity (ROE)
-52.50%-52.50%-43.20%-122.50%-16.20%-53.30%-22.60%-87.50%48.40%-
Return on Assets (ROA)
-44.30%-44.30%-37.30%-109.30%-11.90%-49.00%-19.00%-79.00%-1731.60%-
Return on Capital (ROIC)
-67.57%-67.57%-39.17%-81.17%117.14%-66.60%-19.06%-122.67%22.53%86.88%
Earnings Yield
-148.39%-132.75%-19.33%-21.95%-9.67%-91.95%-15.07%-17.38%--
FCF Yield
-143.58%-128.45%-16.00%-4.45%-27.51%-95.19%-8.47%-14.69%--
Buyback Yield / Dilution
-19.58%-19.58%-152.27%-250.99%6.04%-19.62%-56.56%-2441.82%82.95%-
Total Shareholder Return
-19.58%-19.58%-152.27%-250.99%6.04%-19.62%-56.56%-2441.82%82.95%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).